Itau Unibanco Holding S.A.’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,952
Closed -$365K 740
2019
Q2
$365K Buy
3,952
+3,724
+1,633% +$354K 0.02% 406
2019
Q1
$14K Hold
228
﹤0.01% 570
2018
Q4
$14K Buy
228
+23
+11% +$1.7K ﹤0.01% 570
2018
Q3
$18K Sell
205
-4,909
-96% -$434K ﹤0.01% 573
2018
Q2
$406K Sell
5,114
-13,968
-73% -$1.16M 0.04% 141
2018
Q1
$1.7M Buy
19,082
+14,410
+308% +$1.38M 0.01% 84
2017
Q4
$487K Buy
4,672
+4,005
+600% +$452K 0.03% 173
2017
Q3
$308K Sell
667
-1,729
-72% -$236K 0.02% 393
2017
Q2
$311K Buy
2,396
+2,087
+675% +$256K 0.04% 153
2017
Q1
$38K Buy
+309
New +$37K ﹤0.01% 266

Other funds holding CELG

Itau Unibanco Holding S.A.'s CELG Position: Q3 2019 in Review

Itau Unibanco Holding S.A. sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,952 shares — an estimated $365K sold.

Itau Unibanco Holding S.A. first reported a position in CELG in Q1 2017 and held it in 10 quarters. The position peaked at $1.7M in Q1 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Itau Unibanco Holding S.A. reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 3,952 Celgene Corp shares in Q3 2019, an estimated $365K.
  • Itau Unibanco Holding S.A. first reported a position in Celgene Corp in Q1 2017 and held it in 10 quarters.
  • Itau Unibanco Holding S.A.'s Celgene Corp position peaked at $1.7M in Q1 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2019, filed 14 Nov 2019.